Introducing Abcepta "Crown" Antibodies!
At Abcepta, we understand the need for an antibody to perform the first and every time used. Having served the research and drug discovery community for over a decade, we understand the importance of in-house development in terms of product consistency, validation, and availability.
Products labeled with a "Crown" meet stringent requirements in terms of specificity, sensitivity, and reproducibility.
- All western blots show bands at the correct molecular weight, and any deviation or additional bands have been verified to be due to post translational modifications, isoforms, or cleavage.
- Results are supported by peer reviewed literature and/or by the most relevant bioinformatics sites, i.e. Human Protein Atlas.
- Many of these products are validated and optimized in additional applications including immunofluorescence and subcellular localization is verified using peer reviewed literature.
- New lots are verified to perform as well or better than the previous lots in each application and species tested.






Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.